These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20124463)

  • 1. Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.
    Hauber AB; Johnson FR; Grotzinger KM; Ozdemir S
    Ann Pharmacother; 2010 Mar; 44(3):479-88. PubMed ID: 20124463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.
    Johnson FR; Ozdemir S; Mansfield C; Hass S; Miller DW; Siegel CA; Sands BE
    Gastroenterology; 2007 Sep; 133(3):769-79. PubMed ID: 17628557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.
    Johnson FR; Hauber B; Özdemir S; Siegel CA; Hass S; Sands BE
    J Manag Care Pharm; 2010 Oct; 16(8):616-28. PubMed ID: 20866166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment practices in adults with chronic immune thrombocytopenia - a European perspective.
    Rodeghiero F; Besalduch J; Michel M; Provan D; Grotzinger K; Thompson G
    Eur J Haematol; 2010 Feb; 84(2):160-8. PubMed ID: 19845743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with refractory immune thrombocytopenic purpura.
    George JN
    J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura.
    Fan H; Zhu HL; Li SX; Lu XC; Zhai B; Guo B; Yao SQ; Liu Y
    Cell Biochem Biophys; 2011 Jan; 59(1):7-12. PubMed ID: 21104159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
    Schiavotto C; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the impact and burden of illness of adult chronic ITP in the US.
    Saleh MN; Fisher M; Grotzinger KM
    Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura.
    McMillan R
    Blood Rev; 2002 Mar; 16(1):51-5. PubMed ID: 11913996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.
    Maloisel F; Andrès E; Zimmer J; Noel E; Zamfir A; Koumarianou A; Dufour P
    Am J Med; 2004 May; 116(9):590-4. PubMed ID: 15093754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients.
    Berti D; Moons P; Dobbels F; Deuson R; Janssens A; De Geest S
    Clin Ther; 2008 Aug; 30(8):1540-52. PubMed ID: 18803995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.
    Louwes H; Vellenga E; Houwerzijl EJ; de Wolf JT
    Ann Hematol; 2001 Dec; 80(12):728-32. PubMed ID: 11797113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies.
    Scandellari R; Allemand E; Vettore S; Plebani M; Randi ML; Fabris F
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):108-13. PubMed ID: 19786938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.